Tirzepatide and lean muscle mass

Body-composition analyses from incretin-drug studies indicate that a meaningful fraction of weight lost is fat-free mass, with estimates often in a range comparable to caloric-restriction diets. Importantly, because total weight loss is large, the absolute fat loss is also large, and ratios of fat-to-lean loss appear broadly similar to other methods.

The widely recommended strategies are adequate dietary protein and resistance (strength) training during weight loss. These are general principles supported by exercise and nutrition science; specific targets should be individualized with a clinician or dietitian, especially given reduced appetite on the drug.

If preserving muscle during weight loss is a goal, the evidence-based levers are straightforward even if the specifics should be individualized. Prioritize adequate protein — a challenge when appetite is suppressed, so protein-forward meals and, if needed, supplementation are often emphasized over filling up on low-protein foods. Include resistance (strength) training at least a couple of times weekly; this is the most direct stimulus for retaining lean mass, and it complements the cardiovascular and metabolic benefits of activity. Lose weight at a measured pace rather than as fast as possible, since extremely rapid loss tends to sacrifice more lean tissue. For older adults, in whom muscle and bone are already at risk, these measures matter even more. Because reduced appetite makes it easy to under-eat protein and skip strength work, building these habits deliberately — ideally with a clinician or dietitian — is part of doing weight loss well rather than merely watching the scale drop. The aim is losing fat while keeping the muscle that supports strength, metabolism and long-term function.